In this line, studies have suggested the Nogo-B receptor (NgBR) as a critical element for Ras activation in breast tumor cells and have reported significant association between the high expression of Nogo-B/NgBR and ER-positive/HER2-negative BC [51,58]. Here, ESR1 is linked to breast cancer.